Skip to main content
. 2022 Nov 17;9:1069113. doi: 10.3389/fnut.2022.1069113

TABLE 1.

Baseline characteristics of the cancer cases and matched controls.

Variables Controls (n = 1,389) Cases (n = 1,389) p-value
Age, y 69.32 ± 7.76 69.32 ± 7.76 0.999
Males, n (%) 779 (56.08) 779 (56.08) 1.000
BMI, kg/m2 25.73 ± 3.60 25.72 ± 3.83 0.953
Baseline SBP, mmHg 148.48 ± 21.26 147.52 ± 21.30 0.237
Baseline DBP, mmHg 83.73 ± 11.33 83.07 ± 11.76 0.134
ALT, U/L 8.05 (7.0, 13.0) 10.0 (7.0, 14.0) 0.148
ALB, g/L 45.43 ± 2.45 44.75 ± 2.97 < 0.001
TG, mmol/L 1.21 (0.86, 1.77) 1.19 (0.84, 1.80) 0.630
TC, mmol/L 6.51 ± 1.23 6.44 ± 1.30 0.202
UA, μmol/L 320.0 (269.0, 371.0) 314.0 (264.0, 374.0) 0.393
HDL-C, mmol/L 1.23 ± 0.24 1.22 ± 0.27 0.795
FBG, mmol/L 6.25 ± 1.71 6.29 ± 1.83 0.626
Creatinine, μmol/L 45.84 (27.03, 51.00) 52.0 (10.0, 64.0) 0.748
Folate, ng/mL 6.14 (4.03,9.66) 6.11 (4.22, 10.12) 0.466
HCY, μmol/L 12.01 (10.31, 14.66) 12.25 (10.06, 15.03) 0.886
Arginine, μg/mL 20.88 (17.34, 25.11) 21.41 (17.94, 26.25) 0.001
Marital status, [married, n (%)] 1144 (82.36) 1178 (84.81) 0.354
High school education or above, n (%) 108 (7.78) 103 (7.42) 0.720
Current smoker, n (%) 334 (24.05) 401 (28.87) 0.011
Current drinker, n (%) 388 (27.93) 370 (26.64) 0.359
History of CKD, n (%) 14 (1.01) 25 (1.80) 0.076
History of CHD, n (%) 0 (0) 165 (11.88) < 0.001*
History of stroke, n (%) 0 (0) 64 (4.61) < 0.001*
Family history of cancer, n (%) 47 (3.38) 50 (3.60) 0.918
Poor sleep quality, n (%) 191 (13.75) 259 (18.65) 0.002
Antihypertensive drug usage, n (%) 494 (35.57) 557 (40.10) 0.014

BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; ALT, alanine aminotransferase; ALB, albumin; TG, triglycerides; TC, total cholesterol; UA, uric acid; HDL-C, high-density lipoprotein cholesterol; FBG, fasting blood glucose; HCY, homocysteine; CKD, chronic kidney disease; CHD, coronary heart disease. *Compared by Fisher’s exact test.